Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 6
2002 8
2003 5
2004 2
2005 6
2006 4
2007 2
2008 7
2009 3
2010 4
2011 3
2012 3
2013 8
2014 3
2015 4
2016 5
2017 6
2018 11
2019 6
2020 2
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Results by year
Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
Mazieres J, Drilon A, Lusque A, Mhanna L, Cortot AB, Mezquita L, Thai AA, Mascaux C, Couraud S, Veillon R, Van den Heuvel M, Neal J, Peled N, Früh M, Ng TL, Gounant V, Popat S, Diebold J, Sabari J, Zhu VW, Rothschild SI, Bironzo P, Martinez-Marti A, Curioni-Fontecedro A, Rosell R, Lattuca-Truc M, Wiesweg M, Besse B, Solomon B, Barlesi F, Schouten RD, Wakelee H, Camidge DR, Zalcman G, Novello S, Ou SI, Milia J, Gautschi O. Mazieres J, et al. Among authors: mascaux c. Ann Oncol. 2019 Aug 1;30(8):1321-1328. doi: 10.1093/annonc/mdz167. Ann Oncol. 2019. PMID: 31125062 Free PMC article.
Immune evasion before tumour invasion in early lung squamous carcinogenesis.
Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, Buttard B, Rothe F, Willard-Gallo K, Haller A, Ninane V, Burny A, Sculier JP, Spira A, Galon J. Mascaux C, et al. Nature. 2019 Jul;571(7766):570-575. doi: 10.1038/s41586-019-1330-0. Epub 2019 Jun 26. Nature. 2019. PMID: 31243362
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
Jeanson A, Tomasini P, Souquet-Bressand M, Brandone N, Boucekine M, Grangeon M, Chaleat S, Khobta N, Milia J, Mhanna L, Greillier L, Biemar J, Nanni I, Ouafik L, Garcia S, Mazières J, Barlesi F, Mascaux C. Jeanson A, et al. Among authors: mascaux c. J Thorac Oncol. 2019 Jun;14(6):1095-1101. doi: 10.1016/j.jtho.2019.01.011. Epub 2019 Feb 6. J Thorac Oncol. 2019. PMID: 30738221 Free article.
Personalised medicine for nonsmall cell lung cancer.
Mascaux C, Tomasini P, Greillier L, Barlesi F. Mascaux C, et al. Eur Respir Rev. 2017 Nov 15;26(146):170066. doi: 10.1183/16000617.0066-2017. Print 2017 Dec 31. Eur Respir Rev. 2017. PMID: 29141962 Free article. Review.
Biological basis of anemia.
Bron D, Meuleman N, Mascaux C. Bron D, et al. Among authors: mascaux c. Semin Oncol. 2001 Apr;28(2 Suppl 8):1-6. doi: 10.1016/s0093-7754(01)90205-2. Semin Oncol. 2001. PMID: 11395845 Review.
Evasion before invasion: Pre-cancer immunosurveillance.
Angelova M, Mascaux C, Galon J. Angelova M, et al. Among authors: mascaux c. Oncoimmunology. 2021 Apr 25;10(1):1912250. doi: 10.1080/2162402X.2021.1912250. Oncoimmunology. 2021. PMID: 33996263 Free PMC article.
[Hemoptysis].
Mascaux C, Leurquin M, Ninane V, Delaunois L, André L, Sculier JP. Mascaux C, et al. Rev Med Brux. 2000 Feb;21(1):29-33. Rev Med Brux. 2000. PMID: 10748685 French.
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Boyer A, Pasquier E, Tomasini P, Ciccolini J, Greillier L, Andre N, Barlesi F, Mascaux C. Boyer A, et al. Among authors: mascaux c. Eur Respir Rev. 2018 Mar 14;27(147):170098. doi: 10.1183/16000617.0098-2017. Print 2018 Mar 31. Eur Respir Rev. 2018. PMID: 29540495 Free article. Review.
98 results